842 related articles for article (PubMed ID: 36219347)
1. The role of the gut microbiota in health and cardiovascular diseases.
Wang L; Wang S; Zhang Q; He C; Fu C; Wei Q
Mol Biomed; 2022 Oct; 3(1):30. PubMed ID: 36219347
[TBL] [Abstract][Full Text] [Related]
2. Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease.
Wen Y; Sun Z; Xie S; Hu Z; Lan Q; Sun Y; Yuan L; Zhai C
J Multidiscip Healthc; 2022; 15():2591-2603. PubMed ID: 36388628
[TBL] [Abstract][Full Text] [Related]
3. Update on gut microbiota in cardiovascular diseases.
Qian B; Zhang K; Li Y; Sun K
Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota and Cardiovascular System: An Intricate Balance of Health and the Diseased State.
Bhat MA; Mishra AK; Tantray JA; Alatawi HA; Saeed M; Rahman S; Jan AT
Life (Basel); 2022 Nov; 12(12):. PubMed ID: 36556351
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota.
Alhajri N; Khursheed R; Ali MT; Abu Izneid T; Al-Kabbani O; Al-Haidar MB; Al-Hemeiri F; Alhashmi M; Pottoo FH
Microorganisms; 2021 Sep; 9(10):. PubMed ID: 34683334
[TBL] [Abstract][Full Text] [Related]
6. Immune mechanism of gut microbiota and its metabolites in the occurrence and development of cardiovascular diseases.
Lu J; Jin X; Yang S; Li Y; Wang X; Wu M
Front Microbiol; 2022; 13():1034537. PubMed ID: 36590426
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic activities of succinate: The interplay between gut microbiota and cardiovascular diseases.
Xu J; Yang Y; Li X; Ding S; Zheng L; Xiong C; Yang Y
Imeta; 2023 Aug; 2(3):e124. PubMed ID: 38867936
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota and cardiovascular diseases axis.
Moldovan DC; Ismaiel A; Fagoonee S; Pellicano R; Abenavoli L; Dumitrascu DL
Minerva Med; 2022 Feb; 113(1):189-199. PubMed ID: 33969961
[TBL] [Abstract][Full Text] [Related]
9. Probiotics, gut microbiome, and cardiovascular diseases: An update.
Dosh L; Ghazi M; Haddad K; El Masri J; Hawi J; Leone A; Basset C; Geagea AG; Jurjus R; Jurjus A
Transpl Immunol; 2024 Apr; 83():102000. PubMed ID: 38262540
[TBL] [Abstract][Full Text] [Related]
10. Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation.
Shi B; Li H; He X
Gut Microbes; 2024; 16(1):2323237. PubMed ID: 38411391
[TBL] [Abstract][Full Text] [Related]
11. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.
Rahman MM; Islam F; -Or-Rashid MH; Mamun AA; Rahaman MS; Islam MM; Meem AFK; Sutradhar PR; Mitra S; Mimi AA; Emran TB; Fatimawali ; Idroes R; Tallei TE; Ahmed M; Cavalu S
Front Cell Infect Microbiol; 2022; 12():903570. PubMed ID: 35795187
[TBL] [Abstract][Full Text] [Related]
12. The role of the gut microbiome and its metabolites in cerebrovascular diseases.
Xu H; Xu Z; Long S; Li Z; Jiang J; Zhou Q; Huang X; Wu X; Wei W; Li X
Front Microbiol; 2023; 14():1097148. PubMed ID: 37125201
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review).
Zhu Y; Shui X; Liang Z; Huang Z; Qi Y; He Y; Chen C; Luo H; Lei W
Int J Mol Med; 2020 Sep; 46(3):936-948. PubMed ID: 32705240
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy.
Hsu CN; Hou CY; Hsu WH; Tain YL
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371800
[TBL] [Abstract][Full Text] [Related]
15. The role of intestinal microbiota in cardiovascular disease.
Jin M; Qian Z; Yin J; Xu W; Zhou X
J Cell Mol Med; 2019 Apr; 23(4):2343-2350. PubMed ID: 30712327
[TBL] [Abstract][Full Text] [Related]
16. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
17. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases.
Sanchez-Rodriguez E; Egea-Zorrilla A; Plaza-Díaz J; Aragón-Vela J; Muñoz-Quezada S; Tercedor-Sánchez L; Abadia-Molina F
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32110880
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in modulation of cardiovascular diseases by the gut microbiota.
Masenga SK; Hamooya B; Hangoma J; Hayumbu V; Ertuglu LA; Ishimwe J; Rahman S; Saleem M; Laffer CL; Elijovich F; Kirabo A
J Hum Hypertens; 2022 Nov; 36(11):952-959. PubMed ID: 35469059
[TBL] [Abstract][Full Text] [Related]
19. The role and mechanisms of gut microbiota in diabetic nephropathy, diabetic retinopathy and cardiovascular diseases.
Lv Q; Li Z; Sui A; Yang X; Han Y; Yao R
Front Microbiol; 2022; 13():977187. PubMed ID: 36060752
[TBL] [Abstract][Full Text] [Related]
20. Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease.
Lu Y; Zhang Y; Zhao X; Shang C; Xiang M; Li L; Cui X
Front Cardiovasc Med; 2022; 9():900381. PubMed ID: 36035928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
